CEO SUMMARY: Two regional pathology super-practices have emerged in Washington State. In each case, acquisitions and mergers are fueling the growth of the two large pathology groups. In Western Washington and the Seattle metro, CellNetix is the dominant pathology group, with 53 physicians. The sphere of influence for Incyte Diagnostics and its 40 pathologists is
Tag: incyte pathology
Much is happening in the anatomic pathology market in the Pacific Northwest. PAML, LLC (Spokane, Washington), and CellNetix (Seattle, Washington) finally executed the agreement whereby PAML made an equity investment in CellNetix. Now, the two lab companies will collaborate on developing a reference and esoteric anatomic pathology testing service with national ambitions. Within days of
BY ANY MEASURE, MAJOR CHANGES ARE COMING to the profession of laboratory medicine. I assume that you are familiar with most of the trends, healthcare reforms, and significant reductions in lab test reimbursement that appear regularly in the headlines.
Many of these developments are unfavorable to the status quo in today’s lab testing marketplace. At the
CEO SUMMARY: For labs and all healthcare providers, the risk of an audit is growing because the number of auditors seeking overpayments is rising. In their efforts to eliminate waste and make the Medicare and state Medicaid programs more efficient, federal officials have introduced several different audit programs in recent years. A consultant who helps
CEO SUMMARY: Last summer, InCyte Pathology in Spokane, Washington, found itself facing demand letters from the recovery audit contractor (RAC) responsible for that region. The RAC auditor was questioning claims for technical component (TC) services and seeking repayment from InCyte Pathology. It took three months and plenty of dogged determination for the InCyte team to
Two laboratory companies based in Spokane, Washington, were recently recognized in a list of Washington State’s “100 Best Companies to Work For” in 2011. One was Incyte Pathology, Inc., an anatomic pathology group. The other was Pathology Associates Medical Laboratories (PAML). The list was compiled by Seattle Business magazine. Over 300 companies were involved in
CEO SUMMARY: In eastern Washington State, InCyte Pathology is developing a strategy that may well be repeated many times over in the coming years. As older pathologists who run smaller groups look to retire, they will consider selling their group practices to larger entities interested in forming regional pathology groups. These larger groups will consolidate
CEO SUMMARY: For the nation’s thousands of private pathology group practices, consolidation is now a growing trend. The latest example is last week’s acquisition of the three-pathologist practice known as the Davis-Sameh-Meeker Laboratory in Walla Walla, Washington, by InCyte Pathology, P.S., of Spokane Valley. There are growing numbers of these mergers and consolidations involving independent
WHEN JANUARY 1, 2011, ARRIVED, IT MARKED AN IMPORTANT MILESTONE for the anatomic pathology profession. That is the day that the oldest pathologists in the Baby Boomer generation turned 65 years old and became eligible for Social Security and Medicare.
This is an event we have discussed our entire adult lives. The question is asked constantly.